# EDGAR Filing Document

**Accession Number:** 0002022416
**File Stem:** 0001178913-25-003280
**Filing Date:** 2025-9
**Character Count:** 2336
**Document Hash:** 91f59a97a5c80078b2a20f4698904e85
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001178913-25-003280.hdr.sgml**: 20251205

**ACCESSION NUMBER**: 0001178913-25-003280

**CONFORMED SUBMISSION TYPE**: CORRESP

**PUBLIC DOCUMENT COUNT**: 2

**FILED AS OF DATE**: 20250909

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Silexion Therapeutics Corp
- **CENTRAL INDEX KEY:** 0002022416
- **STANDARD INDUSTRIAL CLASSIFICATION:** BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 000000000
- **STATE OF INCORPORATION:** E9
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** CORRESP

**BUSINESS ADDRESS:**
- **STREET 1:** 12 ABBA HILLEL ROAD
- **CITY:** RAMAT GAN
- **STATE:** L3
- **ZIP:** 5250606
- **BUSINESS PHONE:** 972-8-6286005

**MAIL ADDRESS:**
- **STREET 1:** 12 ABBA HILLEL ROAD
- **CITY:** RAMAT GAN
- **STATE:** L3
- **ZIP:** 5250606

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Biomotion Sciences
- **DATE OF NAME CHANGE:** 20240506

------

![](image0.jpg)

September 9, 2025

#### VIA FACSIMILE AND EDGAR
U.S. Securities and Exchange Commission

Division of Corporate Finance

Washington, DC 20549

---

| | |
|:---|:---|
| **Re:** | **Silexion Therapeutics Corp** |
|  | **Registration Statement on Form S-1 (Registration No. 333-290074) -** |
|  | **Concurrence in Acceleration Request** |

---

Ladies and Gentlemen:

H.C. Wainwright & Co., LLC ("<u>Wainwright</u>"), solely acting as placement agent on a best-efforts basis in an offering pursuant to the registration statement on Form S-1 (333-290074) (the "<u>Registration Statement</u>"), hereby concurs in the request by Silexion Therapeutics Corp that the effective date of the above-referenced registration statement be accelerated to 9:00 A.M. Eastern Time on Thursday, September 11, 2025, or as soon as practicable thereafter, pursuant to Rule 461 under the Securities Act. Wainwright affirms that it is aware of its obligations under the Securities Act as they pertain to the best efforts offering pursuant to the Registration Statement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Very truly yours,<br>**H.C. WAINWRIGHT & CO., LLC**<br>By: *<u>/s/ Edward D. Silvera</u>*<br>Name: Edward D. Silvera<br> Title: Chief Operating Officer<br>

430 Park Avenue \| New York, NY 10022 \| 212.356.0500 \| www.hcwco.com

Member: FINRA/SIPC

------